Middle East & Africa Eye Drops Market Forecast to 2030
Middle East & Africa Eye Drops Market Forecast to 2030 – Regional Analysis – by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application {Eye Diseases (Dry Eye, Glaucoma, Cataract, and Others), Eye Care, and Others}, and Purchase Mode (OTC and Prescription)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Changing Lifestyle Fuels Middle East & Africa Eye Drops Market
Eye diseases hold a substantial share in lifestyle diseases due to the increased use of smartphones, laptops, and computers. The modern lifestyle, which involves increased screen time, is responsible for triggering eye-related problems. Eye health is significantly compromised in this technological era. Working on computers for a long time eventually affects the health of the eyes. Individuals with chronic eye problems and refractive errors are at higher risk of developing digital eye strain (DES).
Extreme exposure to blue rays emitting from smartphones, tablets, iPads, and laptops also causes serious eye damage. Due to the COVID-19 outbreak, all companies opted for work-from-home (WFH) to prevent the spread of COVID-19. The growing trend of WFH has intensified the screen time of working professionals, further accelerating the number of eye-related issues. According to a study published by the Springer, during the COVID-19 lockdown, increase in longer time usage of digital devices, population in Saudi Arabia complained about increase eye strain. According to a study published by Frontiers, the repeated use of digital devices for more than two continuous hours is putting the user at a great risk of developing DES due to the excessive accommodative demands. Although the spread of COVID-19 has been controlled to a large extent, many companies have allowed their employees to continue with WFH to decrease the overall expenditure. This flexibility with regard to work location has led to an increase in screen time. Such lifestyle changes will eventually damage eye health, generating a greater demand for eye drops.
Middle East & Africa Eye Drops Market Overview
The Middle East & Africa eye drops market t is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Increase in prevalence of eye diseases in geriatric population of the region and increase in cases of dry eye diseases and cataract in countries such as Saudi Arabia, and UAE is fueling the growth of Middle East & Africa eye drops market in Middle East & Africa. The majority of dry eye conditions are associated with diabetes. The incidence of diabetes is increasing significantly in South Africa. According to the International Diabetes Federation, as of April 2020, 19 million people were living with diabetes in the country, and the number is estimated to reach 47 million by 2045. Such a high incidence would result in an increased risk of dry eye among diabetic people. Diversified climatic conditions with extreme temperature is another prime factor contributing to the growing incidence of dry eye condition. According to Statistics South Africa (Stats SA) estimates, the population of South Africa was ~59.62 million by mid-2020 and roughly 5.43 million people are aged 60 and above. The association of dry eye with old age is an influential factor boosting the adoption of eye drops in South Africa.
Middle East & Africa Eye Drops Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Eye Drops Market Segmentation
The Middle East & Africa eye drops market is segmented into type, application, purchase mode, and country.
Based on type, the Middle East & Africa eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the Middle East & Africa eye drops market in 2022.
Based on application, the Middle East & Africa eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the Middle East & Africa eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.
Based on purchase mode, the Middle East & Africa eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the Middle East & Africa eye drops market in 2022.
Based on country, the Middle East & Africa eye drops market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa eye drops market in 2022.
AbbVie Inc, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, and Rohto Pharmaceutical Co Ltd are some of the leading companies operating in the Middle East & Africa eye drops market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team Research, the Middle East & Africa eye drops market was valued at US$ 424.84 million in 2022 and is expected to reach US$ 580.44 million by 2030, registering a CAGR of 4.0% from 2022 to 2030. Rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases are the critical factors attributed to the Middle East & Africa eye drops market expansion.
The incidence of ophthalmic diseases such as diabetic retinopathy, glaucoma, and dry eye leading to vision impairment is rising among the population in several countries. A dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. Diabetic retinopathy represents microvascular end-organ damage. It progresses from non-proliferative diabetic retinopathy stages to proliferative diabetic retinopathy. As the disease progresses, associated diabetic macular edema may also become apparent. According to an article published by the American Academy of Ophthalmology, it is estimated that by 2030 an estimated 191 million people globally will suffer from diabetic retinopathy. According to an article published by the World Health Organization (WHO) in 2022, ~2.2 billion people worldwide suffer from near or distant vision impairment. The leading causes of vision impairment are cataracts (~94 million cases) and uncorrected refractive errors (~88.4 million cases). Doctors generally prescribe eye drops for the treatment and prevention of ophthalmic diseases. Hence, the increasing prevalence of ophthalmic diseases is fueling the growth of the Middle East & Africa eye drops market.
On the contrary, Product recalls hampers the Middle East & Africa Eye Drops Market.
Based on type, the Middle East & Africa eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held 39.1% share of Middle East & Africa eye drops market in 2022, amassing US$ 166.18 million. It is projected to garner US$ 231.29 million by 2030 to expand at 4.2% CAGR during 2022–2030.
Based on application, the Middle East & Africa eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held 64.3% share of Middle East & Africa eye drops market in 2022, amassing US$ 272.98 million. It is projected to garner US$ 369.38 million by 2030 to expand at 3.9% CAGR during 2022–2030. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.
Based on purchase mode, the Middle East & Africa eye drops market is segmented into OTC and prescription. The prescription segment held 58.0% share of Middle East & Africa Eye Drops Market in 2022, amassing US$ 246.31 million. It is projected to garner US$ 344.26 million by 2030 to expand at 4.3% CAGR during 2022–2030.
Based on country, the Middle East & Africa eye drops market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 35.5% share of Middle East & Africa eye drops market in 2022. It was assessed at US$ 150.73 million in 2022 and is likely to hit US$ 215.23 million by 2030, exhibiting a CAGR of 4.6% during 2022–2030.
Key players operating in the Middle East & Africa eye drops market are AbbVie Inc, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, and Rohto Pharmaceutical Co Ltd, among others.
In June 2023, Bausch + Lomb Corporation has entered into a definitive agreement with Novartis under which Bausch + Lomb will acquire XIIDRA (lifitegrast ophthalmic solution) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease (DED) focusing on inflammation associated with dry eye.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Eye Drops Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Eye Drops Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
4.3 Pipeline Analysis
5. Middle East & Africa Eye Drops Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Ophthalmic Diseases
5.1.2 High Incidence of Age-Related Eye Diseases
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Rising Initiatives for Eye Care
5.4 Future Trends
5.4.1 Changing Lifestyle
5.5 Impact Analysis
6. Eye Drops Market – Middle East & Africa Market Analysis
6.1 Middle East & Africa Eye Drops Market Revenue (US$ Mn), 2022 – 2030
7. Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Middle East & Africa Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Antibiotics
7.3.1 Overview
7.3.2 Antibiotics: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Artificial Tears
7.4.1 Overview
7.4.2 Artificial Tears: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Hormones
7.5.1 Overview
7.5.2 Hormones: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Middle East & Africa Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Eye Diseases
8.3.1 Overview
8.3.2 Eye Diseases: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Dry Eye
8.3.2.1.1 Overview
8.3.2.2 Dry Eye: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Glaucoma
8.3.2.3.1 Overview
8.3.2.3.2 Glaucoma: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Cataract
8.3.2.4.1 Overview
8.3.2.4.2 Cataract: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Others
8.3.2.5.1 Overview
8.3.2.5.2 Others: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Eye Care
8.4.1 Overview
8.4.2 Eye Care: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 – by Purchase Mode
9.1 Overview
9.2 Middle East & Africa Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
9.3 Prescription
9.3.1 Overview
9.3.2 Prescription: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9.4 OTC
9.4.1 Overview
9.4.2 OTC: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Middle East & Africa Eye Drops Market
10.1.1 Overview
10.1.1.1 South Africa: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 South Africa: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 South Africa: Middle East & Africa Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.1.1.4 South Africa: Middle East & Africa Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.1.1.4.1 South Africa: Middle East & Africa Eye Drops Market, by Eye Disease by Application, 2020–2030 (US$ Million)
10.1.1.1.5 South Africa: Middle East & Africa Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.1.2 Saudi Arabia: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Saudi Arabia: Middle East & Africa Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.1.2.4 Saudi Arabia: Middle East & Africa Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.1.2.4.1 Saudi Arabia: Middle East & Africa Eye Drops Market, by Eye Disease by Application, 2020–2030 (US$ Million)
10.1.1.2.5 Saudi Arabia: Middle East & Africa Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.1.3 UAE: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UAE: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 UAE: Middle East & Africa Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.1.3.4 UAE: Middle East & Africa Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.1.3.4.1 UAE: Middle East & Africa Eye Drops Market, by Eye Disease by Application, 2020–2030 (US$ Million)
10.1.1.3.5 UAE: Middle East & Africa Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa Eye Drops Market, by Eye Disease by Application, 2020–2030 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
11. Middle East & Africa Eye Drops Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Eye Drops Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Alcon AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pfizer Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Rohto Pharmaceutical Co Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AbbVie Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bausch & Lomb Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Eye Drops Market Segmentation
Table 2. South Africa: Middle East & Africa Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 3. South Africa: Middle East & Africa Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 4. South Africa: Middle East & Africa Eye Drops Market, by Eye Disease by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. South Africa: Middle East & Africa Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia: Middle East & Africa Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia: Middle East & Africa Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia: Middle East & Africa Eye Drops Market, by Eye Disease by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia: Middle East & Africa Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 10. UAE: Middle East & Africa Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. UAE: Middle East & Africa Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. UAE: Middle East & Africa Eye Drops Market, by Eye Disease by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. UAE: Middle East & Africa Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of Middle East & Africa: Middle East & Africa Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of Middle East & Africa: Middle East & Africa Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of Middle East & Africa: Middle East & Africa Eye Drops Market, by Eye Disease by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Middle East & Africa: Middle East & Africa Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 18. Organic Developments in the Eye Drops Market
Table 19. Inorganic Developments in the Eye Drops Market
Table 20. Glossary of Terms, Middle East & Africa Eye Drops Market
LIST OF FIGURES
Figure 1. Middle East & Africa Eye Drops Market Segmentation, By Country
Figure 2. Middle East & Africa – PEST Analysis
Figure 3. Pipeline Analysis
Figure 4. Middle East & Africa Eye Drops Market: Key Industry Dynamics
Figure 5. Middle East & Africa Eye Drops Market: Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Eye Drops Market Revenue (US$ Mn), 2020 – 2030
Figure 7. Middle East & Africa Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
Figure 8. Antibiotics: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Artificial Tears: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hormones: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East & Africa Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
Figure 13. Eye Diseases: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dry Eye: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Glaucoma: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cataract: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Eye Care: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Middle East & Africa Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
Figure 21. Prescription: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. OTC: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa: Middle East & Africa Eye Drops Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. Middle East & Africa Eye Drops Market, by Country, 2022 & 2030 (%)
Figure 25. South Africa: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Saudi Arabia: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. UAE: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Rest of Middle East & Africa: Middle East & Africa Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Growth Strategies in the Eye Drops Market (%)
List of Companies
o AbbVie Inc
o Alcon AG
o Bausch & Lomb Inc
o Pfizer Inc
o Rohto Pharmaceutical Co Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.